Summit Therapeutics (SMMT) Other Working Capital Changes (2019 - 2025)
Summit Therapeutics' Other Working Capital Changes history spans 7 years, with the latest figure at $4.8 million for Q4 2025.
- For Q4 2025, Other Working Capital Changes fell 34.34% year-over-year to $4.8 million; the TTM value through Dec 2025 reached $4.9 million, down 33.85%, while the annual FY2025 figure was $4.9 million, 33.85% down from the prior year.
- Other Working Capital Changes reached $4.8 million in Q4 2025 per SMMT's latest filing, up from $1000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $7.3 million in Q4 2024 to a low of -$4.5 million in Q4 2022.
- Average Other Working Capital Changes over 5 years is $180052.6, with a median of $25000.0 recorded in 2025.
- The largest YoY upside for Other Working Capital Changes was 1539.45% in 2022 against a maximum downside of 469.24% in 2022.
- A 5-year view of Other Working Capital Changes shows it stood at $1.2 million in 2021, then tumbled by 469.24% to -$4.5 million in 2022, then increased by 19.3% to -$3.7 million in 2023, then soared by 298.86% to $7.3 million in 2024, then crashed by 34.34% to $4.8 million in 2025.
- Per Business Quant, the three most recent readings for SMMT's Other Working Capital Changes are $4.8 million (Q4 2025), $1000.0 (Q3 2025), and $56000.0 (Q2 2025).